drugset / Trial / NCT03311932
A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects
Phase 1
Completed
51 enrolled
Neurocrine UK Limited
Bionical-Emas Pharma Ltd · collabBrush Clinical Research Ltd. · collabMedical Matters International Ltd · collabNichol Pharma Services Ltd. · collabSimbec Research · collabVoet Consulting · collab
RandomizedCrossoverOpen-labelTreatment
Summary
This was a two-part, single centre, open-label, randomised, single dose, two-period, crossover study to evaluate the bioavailability of Infacort® versus Cortef® immediate release hydrocortisone tablets in dexamethasone-suppressed healthy adult male and female subjects in the fasted and fed states.
Timeline
- Start
- 2018-04-16
- Primary completion
- 2018-07-13
- Completion
- 2018-07-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrocortisone | Other / unclassified | 20 mg | — |